GP
RMD icon

Girard Partners’s ResMed RMD Stock Holding History

Girard Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.01M Sell
10,486
-182
-2% -$36.9K 0.19% 93
2024
Q1 		$2.11M Buy
10,668
+1,952
+22% +$358K 0.2% 100
2023
Q4 		$1.5M Sell
8,716
-1,208
-12% -$186K 0.15% 121
2023
Q3 		$1.47M Buy
9,924
+4,123
+71% +$745K 0.17% 117
2023
Q2 		$1.27M Buy
+5,801
New +$1.29M 0.13% 127

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Girard Partners's RMD Position: Q2 2024 in Review

Girard Partners reduced its ResMed (RMD) stake by 1.7% in Q2 2024, selling an estimated $36.9K and leaving 10,486 shares worth $2.01M. The position accounts for 0.19% of the portfolio, ranked #93.

Girard Partners first reported a position in RMD in Q2 2023 and has held it in 5 quarters since. The position peaked at $2.11M in Q1 2024. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Girard Partners held 10,486 shares of ResMed worth $2.01M as of Q2 2024.
  • Girard Partners sold 182 ResMed shares in Q2 2024, an estimated $36.9K.
  • ResMed made up 0.19% of Girard Partners's portfolio in Q2 2024, its #93 holding.
  • Girard Partners first reported a position in ResMed in Q2 2023 and has held it in 5 quarters since.
  • Girard Partners's ResMed position peaked at $2.11M in Q1 2024.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.